Source: Health Products Regulatory Authority (ZA) Revision Year: 2022 Publisher: Cipla Medpro (Pty) Ltd., Building 9, Parc du Cap, Mispel Street, Bellville, 7530, RSA Customer care: 080 222 6662
MUCOSOLV CAPSULES 375 mg.
| Pharmaceutical Form |
|---|
|
Capsules. Orange/white hard gelatin capsules. |
Each capsule contains: carbocisteine 375 mg.
Sugar free.
For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Carbocisteine |
Carbocisteine (5-carboxymethyl L-cysteine) has been shown in normal and bronchitic animal models to affect the nature and amount of mucus glycoprotein that is secreted by the respiratory tract. An increase in the acid:neutral glycoprotein ratio of the mucus and a transformation of serous cells to mucus cells is known to be the initial response to irritation and will normally be followed by hypersecretion. |
| List of Excipients |
|---|
|
Colloidal silicon dioxide |
MUCOSOLV CAPSULES are orange/white hard gelatine capsules.
MUCOSOLV CAPSULES are packed in blister strips of 10 capsules packed in cartons of 30 or 100 capsules per carton.
Not all pack sizes may be marketed.
Cipla Medpro (Pty) Ltd., Building 9, Parc du Cap, Mispel Street, Bellville, 7530, RSA
Customer care: 080 222 6662
W/10.1/57
The date on the registration certificate of the medicine: 19 December 1988
| Drug | Countries | |
|---|---|---|
| MUCOSOLV | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
